CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for JCL Bioassay Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

JCL Bioassay Corporation
7F, Shin-Osaka Daiichi Seimei Bldg.
3-5-24, Miyahara, Yodogawa-ku
Phone: +81 661516700p:+81 661516700 Osaka-Shi, OSK  532-0003  Japan Fax: +81 661516707f:+81 661516707

This company was Merged or Acquired on 3/1/2015.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
JCL Bioassay Corporation is a Japan-based company engaged in the entrusted research and tests related to drug development. The Company is engaged in the bioanalysis (measurement of the concentration of a drug in a biological sample), which is applied in clinical and nonclinical tests, among others. The Company is also involved in the pharmaceutical quality stability tests, including formulation preservation stability tests, drug substance characteristic tests and compatibility tests. The Company operates its business in Japan and the United States. As of March 31, 2013, the Company had one consolidated subsidiary.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20143/31/2014Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Director of Research & Development Support, President and Chief Executive Officer KunioMomiyama 65 4/1/2013 4/1/2005
Managing Director, Director of Research, Manager of Osaka Laboratory Center NorikoInoue 43 4/1/2013 4/1/2005
Director of Administration, Manager of Business Planning Office, Director TakanobuYoshida 40 6/1/2013 6/29/2012
Independent Director HiroshiNakamura 69 6/20/2013 6/20/2013
Independent Director IsaoShibuya 67 6/24/2014 6/24/2014

General Information
Number of Employees: 157 (As of 3/31/2014)
Outstanding Shares: 4,170,915 (As of 12/31/2014)
Shareholders: 2,528
Stock Exchange: TYO
Fax Number: +81 661516707


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023